Bandung, Indonesia, June 18, 2013 - (ACN Newswire) - The Indonesian government has warned Organization of Islamic Cooperation (OIC) member states of new and emerging health related threats.
The warning is raised by Indonesian Health Minister Nafsiah Mboi, in a prepared statement read out by the ministry's Expert Staff for Health Technology and Globalization Professor Dr. Agus Purwadianto, in the opening remarks to expert meeting session of the 2nd meeting of OIC vaccine- and medicine-manufacturer, here, on Tuesday.
Experts and health officials from nine countries (that already have vaccine making companies or institutions) out of the total 57 OIC member states are the 3-day meeting that kicked off last Sunday and is to wrap up on 19 June, 2013.
In the expert meeting with the them "The Meeting to Finalize Draft Implementation Plan for OIC Strategic Health Programme of Action 2013-2020," the minister in the written statement says that Indonesia along with OIC member countries therefore are planning a strategic action of health to deal with the impending threats.
This strategic plan of action is being prepared by taking into account or referring to global strategy and commitment on health development, the minister explains. OIC Secretariat and all OIC member countries are expected to actively play their roles in carrying out all decisions already agreed upon by Islamic Conference of Health Minister (ICHM).
In OIC-Health Programme of Action (OIC-SHPA) meeting in Bandung, Indonesia is the host as well as chair of the meeting as Indonesia was the main initiator of the draft for the implementation plan of OIC-SHPA. This document is the first of its kind within the history of OIC health cooperation.
Also, given the importance of Indonesia's roles in the continuity and finalization of OIC-SHPA documents and being an acting chair of OIC SHPA meeting. In addition, Indonesia is the prospective chairman of the Conference of OIC Health Ministers years 2013-2015 along with deputies chairs Kazakhstan and Turkey.
The 2nd meeting of OIC vaccine- and medicine manufacturers is hosted by Bio Farma, Indonesia's only vaccine manufacturer whose products has been recognized by WHO since 1997 so that it export its products to over 120 countries worldwide.
The needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year.
Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products. It has also implemented green industry and is environment friendly. WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.
Bio Farma products are through the direct distribution or through various agencies such as UNICEF, PAHO. The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010,2011, 2012 as an evidence of its consistent exceptional performance.
About OIC
The Organisation of Islamic Cooperation (OIC) is the second largest inter-governmental organization after the United Nations which has membership of 57 states spread over four continents. The Organization is the collective voice of the Muslim world and ensuring to safeguard and protect the interests of the Muslim world in the spirit of promoting international peace and harmony among various people of the world.
About PT Bio Farma (Persero)
Since its establishment in 1890, PT Bio Farma (Persero) has been active in supplying high quality vaccines and serum for people. Currently, Bio Farma is among the largest vaccines manufacturers and suppliers in the world. The need for EPI vaccines in Indonesia has been supplied solely by Bio Farma.
Bio Farma has existed for a century and proven its strength and experience world wide. The company has also grown and developed to become a vaccine and serum manufacturer of international reputation. This can be seen from its qualifications and ability to acquire WHO prequalification for all of its EPI Vaccine products. For more information, please visit www.biofarma.co.id.
Source: PT Bio Farma (Persero)
Contact:
Copyright 2013 ACN Newswire. All rights reserved.
The warning is raised by Indonesian Health Minister Nafsiah Mboi, in a prepared statement read out by the ministry's Expert Staff for Health Technology and Globalization Professor Dr. Agus Purwadianto, in the opening remarks to expert meeting session of the 2nd meeting of OIC vaccine- and medicine-manufacturer, here, on Tuesday.
Experts and health officials from nine countries (that already have vaccine making companies or institutions) out of the total 57 OIC member states are the 3-day meeting that kicked off last Sunday and is to wrap up on 19 June, 2013.
In the expert meeting with the them "The Meeting to Finalize Draft Implementation Plan for OIC Strategic Health Programme of Action 2013-2020," the minister in the written statement says that Indonesia along with OIC member countries therefore are planning a strategic action of health to deal with the impending threats.
This strategic plan of action is being prepared by taking into account or referring to global strategy and commitment on health development, the minister explains. OIC Secretariat and all OIC member countries are expected to actively play their roles in carrying out all decisions already agreed upon by Islamic Conference of Health Minister (ICHM).
In OIC-Health Programme of Action (OIC-SHPA) meeting in Bandung, Indonesia is the host as well as chair of the meeting as Indonesia was the main initiator of the draft for the implementation plan of OIC-SHPA. This document is the first of its kind within the history of OIC health cooperation.
Also, given the importance of Indonesia's roles in the continuity and finalization of OIC-SHPA documents and being an acting chair of OIC SHPA meeting. In addition, Indonesia is the prospective chairman of the Conference of OIC Health Ministers years 2013-2015 along with deputies chairs Kazakhstan and Turkey.
The 2nd meeting of OIC vaccine- and medicine manufacturers is hosted by Bio Farma, Indonesia's only vaccine manufacturer whose products has been recognized by WHO since 1997 so that it export its products to over 120 countries worldwide.
The needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year.
Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products. It has also implemented green industry and is environment friendly. WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.
Bio Farma products are through the direct distribution or through various agencies such as UNICEF, PAHO. The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010,2011, 2012 as an evidence of its consistent exceptional performance.
About OIC
The Organisation of Islamic Cooperation (OIC) is the second largest inter-governmental organization after the United Nations which has membership of 57 states spread over four continents. The Organization is the collective voice of the Muslim world and ensuring to safeguard and protect the interests of the Muslim world in the spirit of promoting international peace and harmony among various people of the world.
About PT Bio Farma (Persero)
Since its establishment in 1890, PT Bio Farma (Persero) has been active in supplying high quality vaccines and serum for people. Currently, Bio Farma is among the largest vaccines manufacturers and suppliers in the world. The need for EPI vaccines in Indonesia has been supplied solely by Bio Farma.
Bio Farma has existed for a century and proven its strength and experience world wide. The company has also grown and developed to become a vaccine and serum manufacturer of international reputation. This can be seen from its qualifications and ability to acquire WHO prequalification for all of its EPI Vaccine products. For more information, please visit www.biofarma.co.id.
Source: PT Bio Farma (Persero)
Contact:
M. Rahman Rustan Corporate Secretary Bio Farma +62 22 2033755 +62 22 2041306 e-mail : pr@biofarma.co.id
Copyright 2013 ACN Newswire. All rights reserved.
© 2013 JCN Newswire
